Dr Emma Scales-Theobald
Academic and research departments
School of Veterinary Medicine, Centre for Vision, Speech and Signal Processing (CVSSP).News
In the media
ResearchResearch interests
Postdoctoral researcher in canine behaviour and health research. Research has involved topics such as using technology to detect lameness in dogs, wearable technology, AI, Chiari-like malformation and syringomyelia, Health-related Quality of Life (HRQoL), behavioural biomarkers of canine dementia/cognitive dysfunction and osteoarthritis, chronobiology and other canine research.
Research interests
Postdoctoral researcher in canine behaviour and health research. Research has involved topics such as using technology to detect lameness in dogs, wearable technology, AI, Chiari-like malformation and syringomyelia, Health-related Quality of Life (HRQoL), behavioural biomarkers of canine dementia/cognitive dysfunction and osteoarthritis, chronobiology and other canine research.
Publications
Canine Chiari-like malformation (CM) is a neuroanatomical condition associated with conformational change of the cranium, craniocervical junction and neuroparenchyma, resulting in pain (Chiari associated pain or CM-P) and the development of syringomyelia (SM). The associated neuro-disability in affected individuals compromises quality of life. CM is characterized by overcrowding of the brain and cervical spinal cord and is predisposed by skull-base shortening and miniaturization with brachycephalic toy dogs overwhelmingly represented. Magnetic resonance imaging (MRI) is conventionally used for diagnosis; however, CM is complex and ubiquitous in some dog breeds so that diagnosis of CM-P relies on a combination of clinical signs, MRI, and elimination of other causes of pain. This research aimed to identify cranial and spinal pathologies and neural morphologies linked to CM-P and SM in dogs using MRI scans and machine learning with the aim of identifying novel data driven biomarkers which could confirm CM-P and identify dogs at risk of developing SM. The methodology identified four regions of interest as having robust discrimination for CM-P, with 89% sensitivity and 76% specificity. A set of morphological features linked to CM-P were identified. Four regions of interest were also identified as having robust discrimination for SM, with 84% sensitivity and 80% specificity. Overall, these findings shed light on the distinct morphologies related to CM-P and SM, offering the potential for more accurate and objective diagnoses in affected dogs using MRI. These results contribute to the further understanding of the complex pathologies associated with CM and SM in brachycephalic toy pure and mixed breed dogs and support the potential utility of data-driven techniques for advancing our knowledge of these debilitating conditions.
Introduction Canine osteoarthritis (OA) causes pain and mobility impairment. This can reduce dog quality of life (QoL), owner QoL and owners’ satisfaction with, and adherence to, treatments. No existing canine OA-specific instrument assesses all three impacts. This study aimed to develop and psychometrically evaluate an owner-completed canine OA-specific measure of dog QoL, owner QoL and owner treatment satisfaction; the “Canine OA Quality of Life and Treatment Satisfaction Questionnaire” (CaOA-QoL-TS). Methods The CaOA-QoL-TS was developed using a conceptual model derived from a meta-synthesis of published literature followed by cognitive interviews with ten owners of dogs with OA, to evaluate content validity. Results Based on interview findings, ten items were reworded, four removed, and two added; resulting in 26 items that all owners understood and considered relevant. The recall period and response options were well understood and appropriate to almost all owners. To evaluate its psychometric properties, the CaOA-QoL-TS (draft 26-item version) was administered, across six timepoints in a phase 4 field study, to owners of OA treated dogs, recruited from veterinary practices (N = 93). Inter-item correlations suggested items clustered into three distinct domains: Dog QoL, Owner QoL and Treatment Satisfaction, as hypothesized. Confirmatory factor analysis supported deletion of two items and calculation of the three domain scores, with acceptable model fit. The resulting 24-item CaOA-QoL-TS instrument demonstrated strong internal consistency and good to excellent test–retest reliability. Convergent validity was supported by moderate to strong correlations with concurrent measures. Known groups validity was supported by statistically significant differences between groups categorized by owner global impression of QoL. Ability to detect change was demonstrated through statistically significant improvements over time in Owner and Dog QoL, with larger within-group effect sizes reported for the mean of ‘improved’ dogs compared to the mean of ‘stable’ dogs. Only a small sample of dogs worsened throughout the study. Anchor-based analyses supported-0.9 and-1.0-point within-group responder definitions for dog and owner QoL domains, respectively. Discussion Findings support the content validity of the CaOA-QoL-TS in canine OA. The 24-item CaOA-QoL-TS is a reliable and valid instrument to measure owner and canine QoL and TS and is sensitive to improvements following OA treatment.